Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical development and approval of COVID-19 vaccines.
Kalinke U, Barouch DH, Rizzi R, Lagkadinou E, Türeci Ö, Pather S, Neels P. Kalinke U, et al. Expert Rev Vaccines. 2022 May;21(5):609-619. doi: 10.1080/14760584.2022.2042257. Epub 2022 Mar 14. Expert Rev Vaccines. 2022. PMID: 35157542 Free PMC article.
The European Regulatory Environment of RNA-Based Vaccines.
Hinz T, Kallen K, Britten CM, Flamion B, Granzer U, Hoos A, Huber C, Khleif S, Kreiter S, Rammensee HG, Sahin U, Singh-Jasuja H, Türeci Ö, Kalinke U. Hinz T, et al. Among authors: kalinke u. Methods Mol Biol. 2017;1499:203-222. doi: 10.1007/978-1-4939-6481-9_13. Methods Mol Biol. 2017. PMID: 27987152 Review.
Innate immune response to SARS-CoV-2 infection contributes to neuronal damage in human iPSC-derived peripheral neurons.
Passos V, Henkel LM, Wang J, Zapatero-Belinchón FJ, Möller R, Sun G, Waltl I, Schneider T, Wachs A, Ritter B, Kropp KA, Zhu S, Deleidi M, Kalinke U, Schulz TF, Höglinger G, Gerold G, Wegner F, Viejo-Borbolla A. Passos V, et al. Among authors: kalinke u. J Med Virol. 2024 Feb;96(2):e29455. doi: 10.1002/jmv.29455. J Med Virol. 2024. PMID: 38323709
B cell depletion impairs vaccination-induced CD8+ T cell responses in a type I interferon-dependent manner.
Graalmann T, Borst K, Manchanda H, Vaas L, Bruhn M, Graalmann L, Koster M, Verboom M, Hallensleben M, Guzmán CA, Sutter G, Schmidt RE, Witte T, Kalinke U. Graalmann T, et al. Among authors: kalinke u. Ann Rheum Dis. 2021 Dec;80(12):1537-1544. doi: 10.1136/annrheumdis-2021-220435. Epub 2021 Jul 5. Ann Rheum Dis. 2021. PMID: 34226189 Free PMC article.
Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?
Gussarow D, Bonifacius A, Cossmann A, Stankov MV, Mausberg P, Tischer-Zimmermann S, Gödecke N, Kalinke U, Behrens GMN, Blasczyk R, Eiz-Vesper B. Gussarow D, et al. Among authors: kalinke u. Front Med (Lausanne). 2021 Nov 25;8:770381. doi: 10.3389/fmed.2021.770381. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34901085 Free PMC article.
RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockade.
Heidegger S, Kreppel D, Bscheider M, Stritzke F, Nedelko T, Wintges A, Bek S, Fischer JC, Graalmann T, Kalinke U, Bassermann F, Haas T, Poeck H. Heidegger S, et al. Among authors: kalinke u. EBioMedicine. 2019 Mar;41:146-155. doi: 10.1016/j.ebiom.2019.02.056. Epub 2019 Mar 6. EBioMedicine. 2019. PMID: 30852164 Free PMC article.
262 results